1. Home
  2. GHLD vs NBTX Comparison

GHLD vs NBTX Comparison

Compare GHLD & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • NBTX
  • Stock Information
  • Founded
  • GHLD 1960
  • NBTX 2003
  • Country
  • GHLD United States
  • NBTX France
  • Employees
  • GHLD N/A
  • NBTX N/A
  • Industry
  • GHLD Finance: Consumer Services
  • NBTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GHLD Finance
  • NBTX Health Care
  • Exchange
  • GHLD Nasdaq
  • NBTX Nasdaq
  • Market Cap
  • GHLD 1.2B
  • NBTX 1.3B
  • IPO Year
  • GHLD 2020
  • NBTX 2020
  • Fundamental
  • Price
  • GHLD $19.86
  • NBTX $17.99
  • Analyst Decision
  • GHLD Hold
  • NBTX Strong Buy
  • Analyst Count
  • GHLD 6
  • NBTX 1
  • Target Price
  • GHLD $18.10
  • NBTX $8.00
  • AVG Volume (30 Days)
  • GHLD 24.9K
  • NBTX 143.2K
  • Earning Date
  • GHLD 11-07-2025
  • NBTX 09-30-2025
  • Dividend Yield
  • GHLD 3.78%
  • NBTX N/A
  • EPS Growth
  • GHLD N/A
  • NBTX N/A
  • EPS
  • GHLD 0.42
  • NBTX N/A
  • Revenue
  • GHLD $1,125,872,000.00
  • NBTX $11,930,711.00
  • Revenue This Year
  • GHLD $1.42
  • NBTX N/A
  • Revenue Next Year
  • GHLD $22.36
  • NBTX $114.97
  • P/E Ratio
  • GHLD $47.55
  • NBTX N/A
  • Revenue Growth
  • GHLD 23.19
  • NBTX N/A
  • 52 Week Low
  • GHLD $11.21
  • NBTX $2.76
  • 52 Week High
  • GHLD $23.57
  • NBTX $30.35
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 54.73
  • NBTX 47.25
  • Support Level
  • GHLD $19.77
  • NBTX $14.78
  • Resistance Level
  • GHLD $20.00
  • NBTX $28.51
  • Average True Range (ATR)
  • GHLD 0.07
  • NBTX 2.03
  • MACD
  • GHLD -0.00
  • NBTX -1.47
  • Stochastic Oscillator
  • GHLD 69.57
  • NBTX 26.24

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: